Artículos de revistas sobre el tema "Virus diseases – Chemotherapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Virus diseases – Chemotherapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq." Journal of Communicable Diseases 55, no. 04 (2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.
Texto completoRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 5 (1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.
Texto completoSnoeck, R., G. Andrei, and E. De Clercq. "Chemotherapy of varicella zoster virus infections." International Journal of Antimicrobial Agents 4, no. 3 (1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.
Texto completoPolsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus." Clinical Infectious Diseases 11, Supplement_7 (1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.
Texto completoHan, Seung Beom, Hye Jo Shin, Eui Soo Lee, et al. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.
Texto completoRice, W. G., and J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy." Reviews in Medical Virology 6, no. 4 (1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.
Texto completoWainberg, Mark A., Andre Dascal, and Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases." Canadian Journal of Infectious Diseases 2, no. 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.
Texto completoFIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy." Journal of Antimicrobial Chemotherapy 24, no. 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.
Texto completoBenke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, et al. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment." Pathogens 12, no. 1 (2023): 129. http://dx.doi.org/10.3390/pathogens12010129.
Texto completoDorobantu, Cristina M., Christian Harak, Rahel Klein та ін. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα". Antimicrobial Agents and Chemotherapy 60, № 10 (2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.
Texto completoRoy, Biswajit G. "Potential of small-molecule fungal metabolites in antiviral chemotherapy." Antiviral Chemistry and Chemotherapy 25, no. 2 (2017): 20–52. http://dx.doi.org/10.1177/2040206617705500.
Texto completoPatel, R., and S. E. Barton. "Antiviral Chemotherapy in Genital Herpes Simplex Virus Infections." International Journal of STD & AIDS 6, no. 5 (1995): 320–28. http://dx.doi.org/10.1177/095646249500600503.
Texto completoDe Clercq, Erik. "Acyclic Nucleoside Phosphonates in the Chemotherapy of DNA Virus and Retrovirus Infections." Intervirology 40, no. 5-6 (1997): 295–303. http://dx.doi.org/10.1159/000150563.
Texto completoYeo, Winnie, Joyce L. Steinberg, John S. Tam, et al. "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy." Journal of Medical Virology 59, no. 3 (1999): 263–69. http://dx.doi.org/10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x.
Texto completoBarsukova, E. N., I. V. Kim, and T. N. Сhekushkina. "IMPROVEMENT AND IN VITRO MICROPROPAGATION OF POTATO VARIETIES FOR DISEASE-FREE SEED GROWING." Far Eastern Agrarian Herald, no. 4 (2018): 20–26. https://doi.org/10.22450/1999-6837-2018-4-20-26.
Texto completoRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 2. Avian, Piscine, Canine, Porcine, Bovine and Equine Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 6 (1992): 311–26. http://dx.doi.org/10.1177/095632029200300601.
Texto completoTien Phat, Do, Pham Bich Ngoc, and Chu Hoang Ha. "Methods to manage, protect and improve plant virus resistance." Vietnam Journal of Biotechnology 19, no. 4 (2022): 607–18. http://dx.doi.org/10.15625/1811-4989/15584.
Texto completoThackray, Alana M., and Hugh J. Field. "Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy." Antimicrobial Agents and Chemotherapy 44, no. 1 (2000): 97–102. http://dx.doi.org/10.1128/aac.44.1.97-102.2000.
Texto completoHirsch, M. S. "Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects." Journal of Infectious Diseases 161, no. 5 (1990): 845–57. http://dx.doi.org/10.1093/infdis/161.5.845.
Texto completoDylewski, J., and L. Thibert. "Failure of Tuberculosis Chemotherapy in a Human Immunodeficiency Virus-Infected Patient." Journal of Infectious Diseases 162, no. 3 (1990): 778–79. http://dx.doi.org/10.1093/infdis/162.3.778.
Texto completoHenrich, Timothy J., Kristen S. Hobbs, Emily Hanhauser, et al. "Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy." Journal of Infectious Diseases 216, no. 2 (2017): 254–62. http://dx.doi.org/10.1093/infdis/jix265.
Texto completoCingarlini, Sara. "Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature." Journal of Clinical Case Studies Reviews & Reports 5, no. 9 (2023): 1–6. http://dx.doi.org/10.47363/jccsr/2023(5)258.
Texto completoIdilman, R., M. Arat, E. Soydan, et al. "Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies." Journal of Viral Hepatitis 11, no. 2 (2004): 141–47. http://dx.doi.org/10.1046/j.1365-2893.2003.00479.x.
Texto completoIshii, T., M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki. "Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis." Antimicrobial Agents and Chemotherapy 40, no. 1 (1996): 241–43. http://dx.doi.org/10.1128/aac.40.1.241.
Texto completoПотапенко, Всеволод Геннадьевич, та М. М. Антонов. "Вторичный гемофагоцитарный синдром и хроническая активная болезнь, ассоциированные с вирусом Эпштейна—Барр (обзор литературы)". Clinical Oncohematology 18, № 3 (2025): 286–92. https://doi.org/10.21320/2500-2139-2025-18-3-286-292.
Texto completoOketani, Makoto, Akio Ido, Hirofumi Uto, and Hirohito Tsubouchi. "Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy." Hepatology Research 42, no. 7 (2012): 627–36. http://dx.doi.org/10.1111/j.1872-034x.2012.00998.x.
Texto completoLocasciulli, A., M. Santamaria, G. Masera, E. Schiavon, A. Alberti, and G. Realdi. "Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy." Journal of Medical Virology 15, no. 1 (1985): 29–33. http://dx.doi.org/10.1002/jmv.1890150105.
Texto completoYeo, Winnie, Paul K. S. Chan, Henry L. Y. Chan, Frankie K. F. Mo, and Philip J. Johnson. "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis." Journal of Medical Virology 65, no. 3 (2001): 473–77. http://dx.doi.org/10.1002/jmv.2060.
Texto completoDe Clercq, Erik. "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections." International Journal of Antimicrobial Agents 7, no. 3 (1996): 193–202. http://dx.doi.org/10.1016/s0924-8579(96)00319-6.
Texto completoIlyushina, Natalia A., Erich Hoffmann, Rachelle Salomon, Robert G. Webster, and Elena A. Govorkova. "Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice." Antiviral Therapy 12, no. 3 (2006): 363–70. http://dx.doi.org/10.1177/135965350701200302.
Texto completoZumla, A., and S. L. Croft. "Chemotherapy and immunity in opportunistic parasitic infections in AIDS." Parasitology 105, S1 (1992): S93—S101. http://dx.doi.org/10.1017/s0031182000075405.
Texto completoSjöberg, Anita Herrström, Liya Wang, and Staffan Eriksson. "Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy." Antimicrobial Agents and Chemotherapy 45, no. 3 (2001): 739–42. http://dx.doi.org/10.1128/aac.45.3.739-742.2001.
Texto completoChen, Jungang, Samantha Kendrick, and Zhiqiang Qin. "Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas." Viruses 11, no. 12 (2019): 1161. http://dx.doi.org/10.3390/v11121161.
Texto completoZon, Robin T., and Michael N. Neuss. "ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases." Journal of Oncology Practice 6, no. 4 (2010): 193–94. http://dx.doi.org/10.1200/jop.777007.
Texto completoYeo, Winnie, Paul K. S. Chan, Pun Hui, et al. "Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study." Journal of Medical Virology 70, no. 4 (2003): 553–61. http://dx.doi.org/10.1002/jmv.10430.
Texto completoKOTLYAR, V. K., S. V. FEDOROVICH, and O. L. SEGET. "IMPROVEMENT OF GRAPE CUTTINGS BY THERMOTHERAPY AGAINST GLRAV-3 VIRUS." Scientific Works of North Caucasian Federal Scientific Center of Horticulture Viticulture Wine-making 37 (September 2023): 107–10. http://dx.doi.org/10.30679/2587-9847-2023-37-107-110.
Texto completoGreiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.133.
Texto completoGreiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.20000133.
Texto completoKorzh, Elena V. "Interstitial lung diseases in persons infected with human immunodeficiency virus." PULMONOLOGIYA 33, no. 6 (2023): 841–48. http://dx.doi.org/10.18093/0869-0189-2023-33-6-841-848.
Texto completoPolyakov, Yu Yu, E. A. Baryakh, E. N. Misyurina, et al. "Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2." Oncohematology 19, no. 2 (2024): 101–8. http://dx.doi.org/10.17650/1818-8346-2024-19-2-101-108.
Texto completoIslas-Muñoz, B., B. Méndez-Sotelo, J. Reyes-Pérez, M. Jiménez-de los Santos, R. Herrera-Goepfert, and P. Volkow-Fernández. "Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C." International Journal of STD & AIDS 31, no. 11 (2020): 1110–13. http://dx.doi.org/10.1177/0956462420943027.
Texto completoUchiyama, Michihiro, Yotaro Tamai, and Takashi Ikeda. "Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma." International Journal of Infectious Diseases 14, no. 3 (2010): e265-e266. http://dx.doi.org/10.1016/j.ijid.2009.04.014.
Texto completoNowak, J. S., and D. Januszkiewicz. "CHEMOTHERAPY OF CHILDREN WITH LYMPHOPROLIFERATIVE DISEASES AS A RISK FACTOR FOR HEPATITIS C VIRUS INFECTION. 127." Pediatric Research 41, no. 5 (1997): 770. http://dx.doi.org/10.1203/00006450-199705000-00146.
Texto completoRamphal, Raveena, Ronald M. Grant, Biljana Dzolganovski, et al. "Herpes Simplex Virus in Febrile Neutropenic Children Undergoing Chemotherapy for Cancer." Pediatric Infectious Disease Journal 26, no. 8 (2007): 700–704. http://dx.doi.org/10.1097/inf.0b013e31805cdc11.
Texto completoPham, Hoang. "Mathematical Modeling the Time-Delay Interactions between Tumor Viruses and the Immune System with the Effects of Chemotherapy and Autoimmune Diseases." Mathematics 10, no. 5 (2022): 756. http://dx.doi.org/10.3390/math10050756.
Texto completoNishida, Tsutomu, Naoki Hiramatsu, Masao Mizuki, et al. "Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic." Hepatology Research 43, no. 4 (2012): 339–46. http://dx.doi.org/10.1111/j.1872-034x.2012.01073.x.
Texto completoShahgolzari, Mehdi, Srividhya Venkataraman, Anne Osano, Paul Achile Akpa, and Kathleen Hefferon. "Plant Virus Nanoparticles Combat Cancer." Vaccines 11, no. 8 (2023): 1278. http://dx.doi.org/10.3390/vaccines11081278.
Texto completoCastelli, Roberto, Riccardo Schiavon, Carlo Preti, and Laurenzia Ferraris. "HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy." Cardiovascular & Hematological Disorders-Drug Targets 20, no. 3 (2020): 175–80. http://dx.doi.org/10.2174/1871529x20666200415121009.
Texto completoLi, Shu, Xiao-Yu Liu, Qiu Pan, et al. "Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells." Viruses 11, no. 4 (2019): 378. http://dx.doi.org/10.3390/v11040378.
Texto completoCesaro, Simone, Mareva Giacchino, Francesca Fioredda, et al. "Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients." BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/707691.
Texto completo